JIN MEDICAL INTERNATIONAL. Ordinary Shares logo
ZJYLJIN MEDICAL INTERNATIONAL. Ordinary Shares
Trade ZJYL now
JIN MEDICAL INTERNATIONAL. Ordinary Shares primary media

About JIN MEDICAL INTERNATIONAL. Ordinary Shares

JIN Medical International (NASDAQ:ZJYL) specializes in the healthcare sector, focusing on the development, manufacturing, and sale of medical devices and pharmaceutical products aimed at improving patient care and healthcare outcomes. The company has a diverse product portfolio that spans various medical disciplines, underscoring its commitment to innovation and quality in addressing the evolving needs of the global healthcare market. JIN Medical International is dedicated to expanding its reach and impact through strategic collaborations, research and development projects, and by entering new markets, with the goal of becoming a key player in the international healthcare industry. Its operations underscore a commitment to excellence, safety, and the well-being of patients worldwide, making it a significant contributor to the medical field.

What is ZJYL known for?

Snapshot

Public US
Ownership
2006
Year founded
269
Employees
Changzhou City, China
Head office
1 of 3
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

Products and/or services of JIN MEDICAL INTERNATIONAL. Ordinary Shares

  • Advanced surgical instruments for minimally invasive procedures, enhancing patient recovery times.
  • Innovative medical imaging devices providing high-resolution images for accurate diagnostics.
  • Durable medical equipment rental services, offering affordability and accessibility to healthcare facilities.
  • Custom healthcare IT solutions, improving patient data management and hospital operational efficiency.
  • Comprehensive telemedicine platforms facilitating remote patient consultations and monitoring.
  • Pharmaceutical distribution of essential drugs, ensuring supply chain reliability for healthcare providers.

JIN MEDICAL INTERNATIONAL. Ordinary Shares executive team

  • Mr. Erqi WangChairman of the Board, President & CEO
  • Mr. Ziqiang WangCFO & Director

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.